News brief
AI drug company Iambic Therapeutics completed a USD 150 million IPO at USD 16 per share, listing on the US stock market.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.iambic.ai ↗Published Oct 15, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
AI制药公司Iambic Therapeutics完成1.5亿美元IPO，发行价每股16美元，登陆美股。